The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
Abstract
Lewy bodies and Lewy neurites are the defining neuropathological characteristics of Parkinson’s disease and dementia with Lewy bodies. They are made of abnormal filamentous assemblies of unknown composition. We show here that Lewy bodies and Lewy neurites from Parkinson’s disease and dementia with Lewy bodies are stained strongly by antibodies directed against amino-terminal and carboxyl-terminal sequences of α-synuclein, showing the presence of full-length or close to full-length α-synuclein. The number of α-synuclein-stained structures exceeded that immunoreactive for ubiquitin, which is currently the most sensitive marker of Lewy bodies and Lewy neurites. Staining for α-synuclein thus will replace staining for ubiquitin as the preferred method for detecting Lewy bodies and Lewy neurites. We have isolated Lewy body filaments by a method used for the extraction of paired helical filaments from Alzheimer’s disease brain. By immunoelectron microscopy, extracted filaments were labeled strongly by anti-α-synuclein antibodies. The morphologies of the 5- to 10-nm filaments and their staining characteristics suggest that extended α-synuclein molecules run parallel to the filament axis and that the filaments are polar structures. These findings indicate that α-synuclein forms the major filamentous component of Lewy bodies and Lewy neurites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, SNCA is a major component of neuronal cytoplasmic deposits known as Lewy bodies (LB) in sporadic PD and dementia with Lewy bodies (DLB) and other proteinaceous inclusions in both glial and neuronal cells in multiple system atrophy (MSA) [7].”
From RNA binding protein AUF1/HNRNPD regulates nuclear export, stability and translation of SNCA transcripts (2023) · cites this paper as [7]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Self-citationMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
Flagged first, then by citations
Research works printed but not linked: 33
- F H Lewy Handbuch der Neurologie 3 , 920–933 (1912).
- M C Trétiakoff Ph.D. thesis (University of Paris, 1919).
- 10.1097/00005072-199603000-00001 · DOI
- 10.1097/00005072-196507000-00003 · DOI
- 10.1002/path.1710990106 · DOI
- 10.1097/00005072-196104000-00007 · DOI
- 10.1007/BF00685366 · DOI
- 10.1111/j.1750-3639.1998.tb00156.x · DOI
- 10.1212/WNL.41.9.1402 · DOI
- 10.1126/science.6308771 · DOI
- M L Schmidt, J Murray, V M-Y Lee, W D Hill, A Wertkin, J Q Trojanowski Am J Pathol 139, 53–65 (1991).
- 10.1097/00005072-199305000-00001 · DOI
- 10.1007/BF00687787 · DOI
- 10.1002/path.1711550105 · DOI · Paper page
- 10.1073/pnas.85.12.4501 · DOI
- 10.1038/ng0298-106 · DOI · Paper page
- 10.1016/0014-5793(94)00395-5 · DOI
- H Ji, J E Liu, T Jia, M Wang, J Liu, G Xiao, B K Joseph, C Rosen, Y E Shi Cancer Res 57, 759–764 (1997).
- 10.1073/pnas.85.8.2854 · DOI
- 10.1073/pnas.87.10.3947 · DOI
- 10.1073/pnas.87.15.5827 · DOI
- 10.1016/0896-6273(92)90117-V · DOI
- 10.1073/pnas.88.6.2288 · DOI
- 10.1016/S0304-3940(97)00891-4 · DOI
- A Takeda, M Mallory, M Sundsmo, W Honer, L Hansen, E Masliah Am J Pathol 152, 367–372 (1998).
- 10.1007/BF00688674 · DOI
- 10.1093/brain/110.5.1131 · DOI
- P G Galloway, P Mulvihill, G Perry Am J Pathol 140, 809–822 (1992).
- T Iwatsubo, H Yamaguchi, M Fujimoro, H Yokosawa, Y Ihara, J Q Trojanowski, V M-Y Lee Am J Pathol 148, 1517–1529 (1996).
- 10.1021/bi961799n · DOI
- 10.1002/j.1460-2075.1985.tb04132.x · DOI
- 10.1006/jmbi.1996.0322 · DOI
- 10.1016/0896-6273(89)90210-9 · DOI · Paper page
Cited by
Sorted by citations
Items 101–108 of 108
Tunneling nanotubes: A novel pharmacological target for neurodegenerative diseases?
Wang, X.-T., Sun, H., Chen, N.-H., & Yuan, Y.-H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105541 · Cited by 22
Comparison of the 3D structures of mouse and human α-synuclein fibrils by solid-state NMR and STEM
Hwang, S., Fricke, P., Zinke, M., Giller, K., Wall, J. S., Riedel, D., Becker, S., & Lange, A. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.04.003 · Cited by 22
A review of proposed mechanisms for neurodegenerative disease
Kelser, B. M., Teichner, E. M., Subtirelu, R. C., & Hoss, K. N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1370580 · Cited by 20
Kattan, F.-G., Koukouraki, P., Anagnostopoulos, A. K., Tsangaris, G. T., & Doxakis, E. (2023) · Open Biology · doi:10.1098/rsob.230158 · Cited by 18
Effects of NAD+ in Caenorhabditis elegans Models of Neuronal Damage
Lee, Y., Jeong, H., Park, K. H., & Kim, K. W. (2020) · Biomolecules · doi:10.3390/biom10070993 · Cited by 8
Kim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7
Sarkosyl differentially solubilizes patient-derived alpha-synuclein fibril strains
Gram, H., Theologidis, V., Boesen, T., & Jensen, P. H. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1177556 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Metadata
- Authors
- Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M.
- Affiliations
- Medical Research Council Centre for Brain Repair and Department of Neurology, University of Cambridge, Robinson Way, Cambridge CB2 2PY, United Kingdom; and Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-05-26
- Volume
- 95
- Issue
- 11
- Pages
- 6469-6473
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 2,868
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review